Literature DB >> 32066556

Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985-2014.

Elena Myasoedova1, John Davis2, Eric L Matteson2, Cynthia S Crowson2,3.   

Abstract

OBJECTIVES: To examine trends in the incidence of rheumatoid arthritis (RA) from 2005 to 2014 overall and by serological status as compared with 1995-2004 and 1985-1994.
METHODS: We evaluated RA incidence trends in a population-based inception cohort of individuals aged ≥18 years who first fulfilled the 1987 American College of Rheumatology (ACR) criteria for RA between 1 January 1985 and 31 December 2014. Incidence rates were estimated and were age-adjusted and sex-adjusted to the white population in the USA in 2010. Trends in incidence were examined using Poisson regression methods.
RESULTS: The 2005-2014 incidence cohort comprised 427 patients: mean age 55.4 years, 68% female, 51% rheumatoid factor (RF) positive and 50% anti-cyclic citrullinated peptide antibody positive. The overall age-adjusted and sex-adjusted annual RA incidence in 2005-2014 was 41/100 000 population (age-adjusted incidence: 53/100 000 in women and 29/100 000 in men). While these estimates were similar to the 1995-2004 decade, there was a decline in the incidence of RF-positive RA in 2005-2014 compared with the previous two decades (p=0.004), with a corresponding increase in RF-negative cases (p<0.001). Smoking rates declined and obesity rates increased from earlier decades to more recent years.
CONCLUSIONS: Significant increase in incidence of RF-negative RA and decrease in RF-positive RA in 2005-2014 compared with previous decades was found using 1987 ACR criteria. The incidence of RA overall during this period remained similar to the previous decade. The changing prevalence of environmental factors, such as smoking, obesity and others, may have contributed to these trends. Whether these trends represent a changing serological profile of RA requires further investigation. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  epidemiology; rheumatoid arthritis; rheumatoid factor

Mesh:

Substances:

Year:  2020        PMID: 32066556      PMCID: PMC7085464          DOI: 10.1136/annrheumdis-2019-216694

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  40 in total

1.  Systemic literature review of the performance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: good news of debatable significance.

Authors:  H Zeidler
Journal:  Ann Rheum Dis       Date:  2013-05-21       Impact factor: 19.103

2.  Evidence of Diagnostic and Treatment Delay in Seronegative Rheumatoid Arthritis: Missing the Window of Opportunity.

Authors:  Caitrin M Coffey; Cynthia S Crowson; Elena Myasoedova; Eric L Matteson; John M Davis
Journal:  Mayo Clin Proc       Date:  2019-10-13       Impact factor: 7.616

3.  Changes in the incidence and prevalence of rheumatoid arthritis in England and Wales, 1970-1982.

Authors:  M C Hochberg
Journal:  Semin Arthritis Rheum       Date:  1990-04       Impact factor: 5.532

4.  Declining trend in the incidence of rheumatoid factor-positive rheumatoid arthritis in Finland 1980-2000.

Authors:  Oili Kaipiainen-Seppanen; Hannu Kautiainen
Journal:  J Rheumatol       Date:  2006-10-01       Impact factor: 4.666

5.  Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status.

Authors:  So-Young Bang; Kyoung-Ho Lee; Soo-Kyung Cho; Hye-Soon Lee; Kyung Wha Lee; Sang-Cheol Bae
Journal:  Arthritis Rheum       Date:  2010-02

6.  The effect of oral contraceptives and estrogen replacement therapy on the risk of rheumatoid arthritis: a population based study.

Authors:  Michele F Doran; Cynthia S Crowson; W Michael O'Fallon; Sherine E Gabriel
Journal:  J Rheumatol       Date:  2004-02       Impact factor: 4.666

7.  The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register.

Authors:  D P Symmons; E M Barrett; C R Bankhead; D G Scott; A J Silman
Journal:  Br J Rheumatol       Date:  1994-08

8.  Comparison of the 1987 American College of Rheumatology and the 2010 American College of Rheumatology/European League against Rheumatism criteria for classification of rheumatoid arthritis in the Nurses' Health Study cohorts.

Authors:  Shanthini Kasturi; Barbara L Goldstein; Susan Malspeis; Elizabeth W Karlson; Karen H Costenbader
Journal:  Rheumatol Int       Date:  2013-09-24       Impact factor: 2.631

9.  Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides.

Authors:  Merete Pedersen; Søren Jacobsen; Mette Klarlund; Bo V Pedersen; Allan Wiik; Jan Wohlfahrt; Morten Frisch
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

10.  Incidence and prevalence of rheumatoid arthritis in Saskatchewan, Canada: 2001-2014.

Authors:  Bindu Nair; Regina Taylor-Gjevre; Liying Wu; Shan Jin; Jacqueline M Quail
Journal:  BMC Rheumatol       Date:  2019-07-18
View more
  40 in total

1.  Establishing Classification Tree Models in Rheumatoid Arthritis Using Combination of Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry and Magnetic Beads.

Authors:  Dan Ma; Nana Liang; Liyun Zhang
Journal:  Front Med (Lausanne)       Date:  2021-02-24

2.  Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging.

Authors:  Maria Vassilaki; Cynthia S Crowson; John M Davis Iii; Stephanie Q Duong; David T Jones; Aivi Nguyen; Michelle M Mielke; Prashanthi Vemuri; Elena Myasoedova
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

3.  Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths.

Authors:  Adrian Gervais; Tom Le Voyer; Jérémie Rosain; Quentin Philippot; Jérémy Manry; Eleftherios Michailidis; Hans-Heinrich Hoffmann; Shohei Eto; Marina Garcia-Prat; Lucy Bizien; Alba Parra-Martínez; Rui Yang; Liis Haljasmägi; Mélanie Migaud; Karita Särekannu; Julia Maslovskaja; Evangelos Vandreakos; Olivier Hermine; Aurora Pujol; Pärt Peterson; Trine H Mogensen; Lee Rowen; James Mond; Xavier de Lamballerie; Xavier Duval; France Mentré; Marie Zins; Pere Soler-Palacin; Roger Colobran; Guy Gorochov; Xavier Solanich; Sophie Susen; Javier Martinez-Picado; Didier Raoult; Marc Vasse; Peter K Gregersen; Lorenzo Piemonti; Carlos Rodríguez-Gallego; Luigi D Notarangelo; Helen C Su; Kai Kisand; Satoshi Okada; Anne Puel; Emmanuelle Jouanguy; Charles M Rice; Pierre Tiberghien; Qian Zhang; Aurélie Cobat; Laurent Abel; Jean-Laurent Casanova; Paul Bastard; Nicolas de Prost; Yacine Tandjaoui-Lambiotte; Charles-Edouard Luyt; Blanca Amador-Borrero; Alexandre Gaudet; Julien Poissy; Pascal Morel; Pascale Richard; Fabrice Cognasse; Jesus Troya; Sophie Trouillet-Assant; Alexandre Belot; Kahina Saker; Pierre Garçon; Jacques G Rivière; Jean-Christophe Lagier; Stéphanie Gentile; Lindsey B Rosen; Elana Shaw; Tomohiro Morio; Junko Tanaka; David Dalmau; Pierre-Louis Tharaux; Damien Sene; Alain Stepanian; Bruno Megarbane; Vasiliki Triantafyllia; Arnaud Fekkar; James R Heath; José Luis Franco; Juan-Manuel Anaya; Jordi Solé-Violán; Luisa Imberti; Andrea Biondi; Paolo Bonfanti; Riccardo Castagnoli; Ottavia M Delmonte; Yu Zhang; Andrew L Snow; Steven M Holland; Catherine Biggs; Marcela Moncada-Vélez; Andrés Augusto Arias; Lazaro Lorenzo; Soraya Boucherit; Boubacar Coulibaly; Dany Anglicheau; Anna M Planas; Filomeen Haerynck; Sotirija Duvlis; Robert L Nussbaum; Tayfun Ozcelik; Sevgi Keles; Ahmed A Bousfiha; Jalila El Bakkouri; Carolina Ramirez-Santana; Stéphane Paul; Qiang Pan-Hammarström; Lennart Hammarström; Annabelle Dupont; Alina Kurolap; Christine N Metz; Alessandro Aiuti; Giorgio Casari; Vito Lampasona; Fabio Ciceri; Lucila A Barreiros; Elena Dominguez-Garrido; Mateus Vidigal; Mayana Zatz; Diederik van de Beek; Sabina Sahanic; Ivan Tancevski; Yurii Stepanovskyy; Oksana Boyarchuk; Yoko Nukui; Miyuki Tsumura; Loreto Vidaur; Stuart G Tangye; Sonia Burrel; Darragh Duffy; Lluis Quintana-Murci; Adam Klocperk; Nelli Y Kann; Anna Shcherbina; Yu-Lung Lau; Daniel Leung; Matthieu Coulongeat; Julien Marlet; Rutger Koning; Luis Felipe Reyes; Angélique Chauvineau-Grenier; Fabienne Venet; Guillaume Monneret; Michel C Nussenzweig; Romain Arrestier; Idris Boudhabhay; Hagit Baris-Feldman; David Hagin; Joost Wauters; Isabelle Meyts; Adam H Dyer; Sean P Kennelly; Nollaig M Bourke; Rabih Halwani; Narjes Saheb Sharif-Askari; Karim Dorgham; Jérome Sallette; Souad Mehlal Sedkaoui; Suzan AlKhater; Raúl Rigo-Bonnin; Francisco Morandeira; Lucie Roussel; Donald C Vinh; Sisse Rye Ostrowski; Antonio Condino-Neto; Carolina Prando; Anastasiia Bonradenko; András N Spaan; Laurent Gilardin; Jacques Fellay; Stanislas Lyonnet; Kaya Bilguvar; Richard P Lifton; Shrikant Mane; Mark S Anderson; Bertrand Boisson; Vivien Béziat; Shen-Ying Zhang; Stéphanie Debette
Journal:  Sci Immunol       Date:  2021-08-19

Review 4.  Global epidemiology of rheumatoid arthritis.

Authors:  Axel Finckh; Benoît Gilbert; Bridget Hodkinson; Sang-Cheol Bae; Ranjeny Thomas; Kevin D Deane; Deshiré Alpizar-Rodriguez; Kim Lauper
Journal:  Nat Rev Rheumatol       Date:  2022-09-06       Impact factor: 32.286

Review 5.  The immunology of rheumatoid arthritis.

Authors:  Cornelia M Weyand; Jörg J Goronzy
Journal:  Nat Immunol       Date:  2020-11-30       Impact factor: 25.606

6.  Increasing incidence of autoantibody-negative RA is replicated and is partly explained by an aging population.

Authors:  Xanthe M E Matthijssen; Tom W J Huizinga; Annette H M van der Helm-van Mil
Journal:  Ann Rheum Dis       Date:  2020-05-29       Impact factor: 19.103

7.  Multimorbidity Burden in Rheumatoid Arthritis: A Population-based Cohort Study.

Authors:  Tina M Gunderson; Elena Myasoedova; John M Davis; Cynthia S Crowson
Journal:  J Rheumatol       Date:  2021-02-15       Impact factor: 5.346

8.  Identification of Tumor Necrosis Factor-Alpha (TNF-α) Inhibitor in Rheumatoid Arthritis Using Network Pharmacology and Molecular Docking.

Authors:  Liang Liang Bai; Hao Chen; Peng Zhou; Jun Yu
Journal:  Front Pharmacol       Date:  2021-05-21       Impact factor: 5.810

9.  Topography of Bone Erosions at the Metatarsophalangeal Joints in Rheumatoid Arthritis: Bilateral Mapping by Computed Tomography.

Authors:  Paolo Simoni; Sakina Moussaddykine; Olivier Malaise; Selma Ben Mustapha; Maria Pilar Aparisi Gómez; Alessandro De Leucio
Journal:  Cureus       Date:  2021-06-22

10.  Identification of the Main Active Components and Mechanism of Wang Bi Tablet in Treating Rheumatoid Arthritis Based on Integrative Pharmacology.

Authors:  Yuanyuan Jiao; Jia Xu; Hong Chen; Qiuyan Guo; Xiaofang Deng; Tong Zhang; Jingbo Zhang; Chenjing Shi; Ping Wang
Journal:  Front Pharmacol       Date:  2021-06-04       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.